Glucose concentration assessment before noncardiac surgery may help clinicians predict the risk for postoperative myocardial injury in patients with and without diabetes.
Using a combination of methodologies suggests higher BMI may increase blood pressure and left ventricular mass index in youth.
Bariatric surgery was associated with significantly lower risk for incident microvascular disease at 5 years.
Greater light and moderate-to-vigorous intensity physical activity were tied to a more favorable cardiac profile in adults aged 60 to 64.
The benefit of adopting a healthy lifestyle was seen even after the type 2 diabetes diagnosis was made.
Increasing screen time trends may have a negative cardiometabolic effect on young children.
Higher HDL cholesterol in postmenopausal women may mask heart disease risk.
Exercising and eating less were top weight loss methods, and more women than men attempted weight loss.
Diagnostic thresholds for gestational diabetes should be adapted using local populations.
A full-nut dose lowered HbA1c and estimated cholesterol levels in LDL particles of a certain diameter.
Small changes in health behaviors were seen in partners of those newly diagnosed with diabetes.
A clinical trial assessing canagliflozin (Invokana; Janssen) as an addition to standard-of-care in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) has been stopped early after meeting its pre-specified efficacy criteria.
The relationship between circadian rhythm and sleep measures and components of metabolic syndrome in patients with bipolar disorder.
Results showed the overall safety profile of linagliptin in study patients, including adults with kidney disease, was consistent with previous data.
Approximately 12,000 patients took part in the CAMELLIA-TIMI 61 trial in which participants were randomized to either lorcaserin HCl 10mg twice daily or placebo.
Lower risk for incident obesity in offspring whose mothers have healthy BMI and engage in physical activity.
The policy supports evidence-based strategies such as excise taxes and adding warning labels.
Investigators examined the relationship between the use of β-blockers and incidence of hypoglycemia and risk for mortality in hospitalized patients with diabetes.
The ITCA 650, a small titanium osmotic mini-pump, provides a subcutaneous infusion of exenatide over 3 or 6 months.
Regardless of presence of preexisting cardiovascular disease, SGLT2 inhibitors were associated with lower risk for death and heart failure.
Lower incidence of major cardiovascular events with Mediterranean diet supplemented with oil and nuts.
To understand the mechanism underlying the benefit of fenofibrate on vascular complications in patients with type 2 diabetes, investigators assessed carotid intima thickness as a marker of subclinical atherosclerosis.
Longer sleep duration and greater sleep efficiency linked to better metabolic risk scores in adolescents.
Investigators sought to determine whether methylglyoxal levels are associated with cardiovascular disease in type 2 diabetes.
Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.
Patients with remitted bipolar disorder and emotional hyper-reactivity also have significantly higher levels of low-grade inflammation, hypertension, and impaired glucose metabolism, indicating a higher risk for cardiometabolic dysfunction.
Investigators examined the frequency of cardiovascular vs noncardiovascular deaths in individuals who developed prediabetes that did not progress to diabetes.
Investigators examined the effect of testosterone replacement therapy on metabolic syndrome and vascular function in obese males with hypogonadism.
Increased mortality from job strain was greater than that from hypertension, obesity, physical inactivity, and high alcohol intake.
Women with metabolically unhealthy normal-weight, overweight, obesity had a considerably higher risk for cardiovascular disease.
The Cardiology Advisor Articles
- AHA/ACC: Updated Management Guidelines for Adult Congenital Heart Disease
- USPSTF Does Not Recommend Afib Screening in Asymptomatic Patients
- American Heart Association Urges Screen Time Limits for Youth
- Patient Connectivity Benefits Familial Chylomicronemia Syndrome
- FDA Approves First Drug Under the Competitive Generic Therapy Pathway
- Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease
- Tricuspid Regurgitation Velocity Unreliable Indicator of Pulmonary Hypertension
- Supplementing Pulmonary Arterial Hypertension Therapy With Nutritional Changes
- The Challenge of Compassion in Modern Healthcare Settings
- Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib
- Extreme Preterm Infants at Risk for Early Age High Blood Pressure
- Anemia Identified as Risk Factor for Contrast-Induced Acute Kidney Injury
- Case: Hypertensive Crisis Following Use of Armodafinil + MAOI
- Triple Combination Pill Can Improve Blood Pressure Control
- Labetalol Use Higher in Patients With Preeclampsia and Asthma